Morbidity and Mortality of Rheumatic Valvulopathy Surgery in Young Adults in Senegal
International Journal of Cardiovascular and Thoracic Surgery
Volume 4, Issue 1, January 2018, Pages: 10-13
Received: Dec. 21, 2017; Accepted: Jan. 16, 2018; Published: Feb. 8, 2018
Views 1013      Downloads 85
Authors
Ciss Amadou Gabriel, Department of Cardiovascular and Thoracic Surgery, Dakar University, Dakar, Senegal
Diop Momar Sokhna, Department of Cardiovascular and Thoracic Surgery, Dakar University, Dakar, Senegal
Sow Ndeye Fatou, Department of Cardiovascular and Thoracic Surgery, Dakar University, Dakar, Senegal
Ba Pape Salmane, Department of Cardiovascular and Thoracic Surgery, Dakar University, Dakar, Senegal
Diagne Papa Amath, Department of Cardiovascular and Thoracic Surgery, Dakar University, Dakar, Senegal
Diatta Souleymane, Department of Cardiovascular and Thoracic Surgery, Dakar University, Dakar, Senegal
Gaye Magaye, Department of Cardiovascular and Thoracic Surgery, Dakar University, Dakar, Senegal
Leye Mohamed, Department of Cardiology, Dakar University, Dakar, Senegal
Sene Etienne Birame, Department of Intensive care and Anesthesiology, Dakar University, Dakar, Senegal
Dieng Papa Adama, Department of Cardiovascular and Thoracic Surgery, Dakar University, Dakar, Senegal
Ndiaye Assane, Department of Cardiovascular and Thoracic Surgery, Dakar University, Dakar, Senegal
Ndiaye Mouhamadou, Department of Cardiovascular and Thoracic Surgery, Dakar University, Dakar, Senegal
Article Tools
Follow on us
Abstract
Rheumatic heart valve disease is the most important cardiovascular diseases in young African people. It’s a cause of a heavy morbidity and mortality. The aim of this study is to evaluate the morbidity and mortality of valve surgery in young adults. It was a retrospective and monocentric study over 2 years. We had evaluated 69 patients with an average age of 32 years [16-63years]. Epidemiological, clinical, paraclinical, interventional and post interventional data were collected from archived patient records. The processing of this data was treated by SPSS v 16 and Excel software. Stage III dyspnea was the main symptom. Risk factors for postoperative mortality were cardiac insufficiency (p=0.006) and aortic valve position (p=0.009). Postoperative complications were dominated by hemodynamic instability (23%), pulmonary complications (20%) and infectious complications (3%). Postoperative mortality was 5.8%. Our late mortality was 2.9%.Two cases of minor accidents to anticoagulation drugs were noted. The evolution was favorable for 85.5% of patients. In Africa, rheumatic heart disease remains the most common valvular heart disease with high morbidity and mortality. Cardiac surgery when it is available improves the quality of life of patients. The high cost of this surgery makes it’s not always available. The prophylaxis of streptococcal bacterial attacks remains the best way for prevention.
Keywords
Morbidity, Mortality, Cardiac Surgery, Rheumatism Heart Disease
To cite this article
Ciss Amadou Gabriel, Diop Momar Sokhna, Sow Ndeye Fatou, Ba Pape Salmane, Diagne Papa Amath, Diatta Souleymane, Gaye Magaye, Leye Mohamed, Sene Etienne Birame, Dieng Papa Adama, Ndiaye Assane, Ndiaye Mouhamadou, Morbidity and Mortality of Rheumatic Valvulopathy Surgery in Young Adults in Senegal, International Journal of Cardiovascular and Thoracic Surgery. Vol. 4, No. 1, 2018, pp. 10-13. doi: 10.11648/j.ijcts.20180401.13
Copyright
Copyright © 2018 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Monsuez. J. Valvulopathies Rhumatismales. AMC Pratique, 2011; 200 (4): 28-31.
[2]
Roudaut. R., Dijos. M., Arsac. F., Reant. P., Lafitte S. Pathologie valvulaire: 50 ans de progrès AMC pratique, 2011; 200 (3): 21-23.
[3]
Essop MR., Nkomo V. T. Rheumatic and NonrheumaticValvular Heart Disease Epidemiology, Management, and Prevention in Africa. Circulation, 2005; 112 (9): 3584-91.
[4]
Lee J. W., Park NH; Shoo SJ; Jo MS; Song H; Song MG. Surgical Outcome of the Maze Procedure for Atrial Fibrillation in Mitral Valve Disease: Rheumatic Versus Degenerative. The Annals of Thoracic Surgery, 2003; 75 (5): 57-6.
[5]
Mbaye A.; Pessinaba S; Bodian M; Ndiaye MB; Mbaye F; Kane A; Diao M. La fibrillation atriale, fréquence; facteurs étiologiques, évolution et traitement dans un service de cardiologie de Dakar, Sénégal. Pan African Medical Journal, 2010; 6, 16 (11): 1-11.
[6]
Antunes M. J. Pulmonary Hypertension in Valve Disease: A beast of the past? The Journal of Thoracic and Cardiovascular Surgery, 2016; 151 (2): 1300-1.
[7]
Cannesson M., Bastien O., Lehot J. J. Particularités de la prise en charge hémodynamique après chirurgie cardiaque. Réanimation, 2005; 14 (9): 216-24.
[8]
Aubert S., Praschker B. L., Coignard E., Gandjbakhch I. La plastie mitrale dans tous ses états. MT cardio, 2008; 4 (6): 291-296.
[9]
Antunes M. J. DeVegaAnnuloplasty of the Tricuspid Valve: Operative Techniques. Thoracic and Cardiovascular Surgery, 2003; 8, 4 (8): 169-76.
[10]
Chassot P. G., Bovi M., Mustaki J. P. Complications après chirurgie cardiaque. Précis d’anesthésie cardiaque, 2012; 23 (65): 1-65.
[11]
Samiei N; Hakimi MR; Peighambari MM; Alizadeh-Ghavidel A; Hossein S. Surgical outcomes of heart valves replacement: A study of tertiary specialied cardiac center. ARYA Atheroscler, 2014; 10 (5): 233-7.
[12]
Carapetis J. R; Powers JR; Currie BJ; Sangster JF; Begg A; Fisher DA; Kilburn CJ; Borrow JNC. Outcomes of Cardiac Valve Replacement for Rheumatic Heart Disease in Aboriginal Australians. Asia Pacific Heart J, 1999; 8, 3 (10): 138-47.
[13]
Alizzi A. M., Knight J. L., Tully P. J. Surgical challenges in rheumatic heart disease in the Australian indigenous population. Heart, Lung and Circulation, 2010; 19 (4): 295-8.
[14]
Kangah M. K; Souaga AK; Amani KA; Kiroua-Kamenan YA; Katche KE; Meneas GC; Kendja KF. La chirurgie valvulaire itérative en Afrique: indications, résultats et facteurs de risque. Chirurgie Thoracique Cardio-Vasculaire, 2010; 15 (4): 93-6.
[15]
Chapelon C., Raguin G., Ziza J. M., Piette J. C., Godeau P. Endocardites infectieuses sur prothèses valvulaires. La revue de médecine interne, 1987; 8 (10): 362-71.
[16]
Clouet J., Simon H., Sellal O., Grimandi G., Duveau D. Le point sur les prothèses valvulaires. Phram Hosp, 2006; 41, 165 (15): 109-23.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186